BPC-157 in India | Prime Peptide

Name: BPC-157
Brand: Prime Peptide
SKU: PR-BPC10
Price: 3999.0 INR
Availability: InStock

PRODUCT OVERVIEW

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide, commonly described as a stable gastric pentadecapeptide fragment. It is studied primarily in preclinical and in-vitro models involving tissue-repair signaling, vascular responses, gastrointestinal integrity, and inflammatory pathways.

This product page presents BPC-157 strictly as laboratory research material and connects the product to reusable research targets, glossary terms, FAQs, and scientific citations.

Purity≥99%

Molecular Weight1,419.5 g/mol

SequenceGEPPPGKPADDAGLV

StorageStore refrigerated at 2–8°C

FormLyophilized powder

Research UseFor in-vitro laboratory research only

Research mechanism Product-specific pathway illustration

RESEARCH AREAS

BPC-157 Potential Use Cases

Product-specific research applications associated with Prime Peptide BPC-157.

Cellular migration and repair-pathway research

Endothelial and angiogenesis-model research

Nitric oxide signaling research

Fibroblast and collagen-response research

Gastrointestinal barrier and cytoprotection models

Tendon and ligament preclinical models

KEY BENEFITS

BPC-157 Research Highlights

Key research-oriented characteristics connected to Prime Peptide BPC-157.

Provides a defined 15-amino-acid research sequence
Supports investigation across vascular, connective-tissue and gastrointestinal models
Suitable for comparative signaling and tissue-response experiments
Available with batch-specific documentation

SPECIFICATIONS

BPC-157 Molecular Data

Molecular specifications for Prime Peptide BPC-157
Molecular Formula	C62H98N16O22
Molecular Weight	1,419.5 g/mol
Purity	≥99%
Appearance	White to off-white powder
Solubility	Solubility can depend on concentration, pH, solvent system, and the supplied batch. Follow the applicable laboratory protocol and batch documentation.
Storage	Store refrigerated at 2–8°C
Research Use	For in-vitro laboratory research only

3D Structure · Representative Model

BIOLOGICAL & MOLECULAR TARGETS

BPC-157 Research Targets

Tendon fibroblast migration

TF migration

Cellular repair process

Tendon fibroblast migration is a cellular process examined in BPC-157 studies. Published in-vitro work reports increased tendon-explant outgrowth and enhanced migration-related responses without directly increasing fibroblast proliferation.

View reference ↗

VEGF-associated angiogenesis

VEGF pathway

Vascular signaling pathway

VEGF-associated angiogenesis describes vascular remodeling studied in muscle and tendon injury models. BPC-157 research has examined changes in VEGF expression and vessel markers during tissue-repair experiments.

View reference ↗

Nitric oxide signaling

NO signaling

Cellular signaling pathway

Nitric oxide signaling is a vascular and cellular pathway frequently evaluated in BPC-157 preclinical models, including studies measuring eNOS expression and nitric-oxide-related responses during tissue repair.

View reference ↗

SCIENTIFIC SOURCES

BPC-157 Citations & References

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

Journal of Applied Physiology 2011

In-vitro and tendon-explant study examining fibroblast outgrowth, cell survival and migration-related responses associated with BPC-157.

Read publication →

Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing

Journal of Physiology and Pharmacology 2010

Preclinical study evaluating VEGF expression and vascular markers in muscle and tendon healing models.

Read publication →

Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing

Cell and Tissue Research 2019

Review of the preclinical literature on BPC-157 and musculoskeletal soft-tissue healing, including tendon, ligament and muscle models.

Read publication →

TERMINOLOGY

BPC-157 Glossary

BPC-157 — A synthetic 15-amino-acid peptide commonly described as a stable gastric pentadecapeptide and studied primarily in preclinical models.

BPC-157 is a 15-amino-acid peptide with the sequence GEPPPGKPADDAGLV. Published literature describes it as a stable gastric pentadecapeptide investigated in preclinical and in-vitro models involving tendon, vascular, gastrointestinal and tissue-repair pathways.

Also known as: BPC 157, Body Protection Compound 157, Stable gastric pentadecapeptide Source ↗

Stable gastric pentadecapeptide — A 15-amino-acid gastric peptide fragment described in the scientific literature as BPC-157.

The term stable gastric pentadecapeptide refers to BPC-157, a 15-amino-acid sequence studied in experimental models of tissue repair and gastrointestinal cytoprotection.

Also known as: Gastric pentadecapeptide, BPC-157 Source ↗

Angiogenesis — The formation and remodeling of blood vessels, a process studied in tissue repair and vascular biology.

Angiogenesis is the biological process through which new blood vessels form from existing vascular structures. In BPC-157 research, angiogenesis has been evaluated using VEGF expression and vascular markers in muscle and tendon models.

Also known as: Neovascularization, Vascular growth Source ↗

Tendon fibroblast — A connective-tissue cell involved in tendon extracellular-matrix maintenance and repair responses.

Tendon fibroblasts are cells that maintain and remodel tendon extracellular matrix. BPC-157 studies have examined their survival, migration and outgrowth in tendon-explant and cell-culture models.

Also known as: Tenocyte, Tendon-derived fibroblast Source ↗

COMMON RESEARCH QUESTIONS

BPC-157 FAQ

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide with the sequence GEPPPGKPADDAGLV. Scientific literature commonly describes it as a stable gastric pentadecapeptide studied mainly in preclinical and in-vitro models.

Which research pathways are studied with BPC-157?

Published studies have investigated tendon-fibroblast migration, cell survival, VEGF-associated angiogenesis, nitric-oxide signaling, gastrointestinal integrity and broader tissue-repair responses. Most of this evidence is preclinical.

Is the published BPC-157 evidence mainly preclinical?

Yes. The literature used for this product page consists primarily of cell-culture, tissue-explant and animal-model studies. Findings from those models should not be treated as established human therapeutic outcomes.

What is the amino-acid sequence of BPC-157?

The commonly reported BPC-157 sequence is GEPPPGKPADDAGLV, a chain of 15 amino acids.

What sources support the BPC-157 research summary?

The summary is supported by peer-reviewed studies indexed in PubMed, including work on tendon fibroblast migration, angiogenesis in muscle and tendon models, and a review of musculoskeletal soft-tissue research. Full references are listed in the Sources section.